Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja Fehm

Showing results (271-280 of 371) with videos related to

Pageof 38
Sort By:
Archives of Gynecology and Obstetrics|September 11, 2015
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study programAmelie Schramm, Thomas W P Friedl, Fabienne Schochter, et al.
Cancer Research|July 23, 2013
SOX2 expression associates with stem cell state in human ovarian carcinomaPetra M Bareiss, Anna Paczulla, Hui Wang, et al.
Cancers|October 1, 2020
Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain MetastasesElena Laakmann, Isabell Witzel, Tanja Neunhöffer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 19, 2019
Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patientsChristiane Matuschek, Carolin Nestle-Kraemling, Jan Haussmann, et al.
Gynecologic Oncology|June 23, 2019
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter studyRüdiger Klapdor, Linn Wölber, Lars Hanker, et al.
Breast Cancer Research : BCR|March 28, 2023
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudyPauline Wimberger, Jens-Uwe Blohmer, Petra Krabisch, et al.
Geburtshilfe Und Frauenheilkunde|August 4, 2017
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)Michael Untch, Jens Huober, Christian Jackisch, et al.
British Journal of Cancer|February 23, 2022
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS CAmelie de Gregorio, Wolfgang Janni, Thomas W P Friedl, et al.
Molecular Cancer Research : MCR|November 10, 2019
EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATMJohanna Naskou, Yvonne Beiter, Ruan van Rensburg, et al.
Pilot and Feasibility Studies|February 12, 2020
Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease-the "Breast cancer care for patients with metastatic disease" (BRE-4-MED) registryStephanie Stangl, Kirsten Haas, Felizitas A Eichner, et al.
Pageof 38

Showing results (271-280 of 371) with videos related to

Sort By:
Pageof 38
Archives of Gynecology and Obstetrics|September 11, 2015
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study programAmelie Schramm, Thomas W P Friedl, Fabienne Schochter, et al.
Cancer Research|July 23, 2013
SOX2 expression associates with stem cell state in human ovarian carcinomaPetra M Bareiss, Anna Paczulla, Hui Wang, et al.
Cancers|October 1, 2020
Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain MetastasesElena Laakmann, Isabell Witzel, Tanja Neunhöffer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 19, 2019
Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patientsChristiane Matuschek, Carolin Nestle-Kraemling, Jan Haussmann, et al.
Gynecologic Oncology|June 23, 2019
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter studyRüdiger Klapdor, Linn Wölber, Lars Hanker, et al.
Breast Cancer Research : BCR|March 28, 2023
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudyPauline Wimberger, Jens-Uwe Blohmer, Petra Krabisch, et al.
Geburtshilfe Und Frauenheilkunde|August 4, 2017
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)Michael Untch, Jens Huober, Christian Jackisch, et al.
British Journal of Cancer|February 23, 2022
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS CAmelie de Gregorio, Wolfgang Janni, Thomas W P Friedl, et al.
Molecular Cancer Research : MCR|November 10, 2019
EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATMJohanna Naskou, Yvonne Beiter, Ruan van Rensburg, et al.
Pilot and Feasibility Studies|February 12, 2020
Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease-the "Breast cancer care for patients with metastatic disease" (BRE-4-MED) registryStephanie Stangl, Kirsten Haas, Felizitas A Eichner, et al.
Pageof 38